معرفی
Noortje de Haan is a Postdoctoral Researcher at the Department of Cellular and Molecular Medicine within the Faculty of Health and Medical Sciences at the University of Copenhagen. She is a member of the Copenhagen Center for Glycomics and works in the Wandall Group, where she conducts research on tissue glycans involved in disease initiation and progression.
Her research focuses on glycomics and glycoproteomics, specializing in the development and application of mass spectrometry-based methods for glycosylation analysis. She uses gene editing, organotypic tissue models, and sophisticated mass spectrometry to decipher glycan functions related to tissue differentiation, cancer, and host-pathogen interactions. Her work aims to exploit this knowledge for developing new treatments for inflammation, cancer, tissue regeneration, and novel viral vaccine strategies.
Dr. de Haan's publications demonstrate expertise in glycan structure-function relationships, with articles appearing in high-impact journals including Nature Communications, Proceedings of the National Academy of Sciences, and Annual Review of Biochemistry. Her research spans diverse applications from gut microbiome interactions to neurodegenerative disease mechanisms and cancer diagnostics.
Her scientific contributions include methodological advancements in glycoproteomics and discoveries related to glycan roles in disease processes, with multiple publications receiving significant attention from news outlets and researchers worldwide.
